Stay updated on AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial
Sign up to get notified when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.

Latest updates to the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page
- Check2 days agoChange DetectedA new revision v3.4.3 is added and revision v3.4.2 is removed from the history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedVersion 6 adds core study record sections—Study Design, Study Description, Sponsor/Collaborators, Study Status, and Study Identification (revision: v3.4.2). It also removes the previous government funding notice and the AnHeart Therapeutics reference.SummaryDifference3%

- Check38 days agoChange DetectedA site-wide notice about government funding was added and the site version updated from v3.4.0 to v3.4.1; the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check45 days agoChange DetectedThe history page now shows a 'Show glossary' option and legends for green additions and red deletions, and the revision version was updated to v3.4.0 with a No FEAR Act Data entry.SummaryDifference1%

- Check59 days agoChange DetectedA new revision entry v3.3.4 appears in the record history with provenance details (AnHeart Therapeutics Inc., 2023-10, verified, unknown status), replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check81 days agoChange DetectedThe record history shows a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure and an older revision entry (v3.3.2), which are minor metadata updates to the site. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.